Peptide record

TPDB05202

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05202
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAMP DRAVP 2.0 APD_complete Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 30-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
Sequence
GLPTCGETCFGGTCNTPGCTCDPWPVCTHN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C126H187N35O43S6
ARQIKMSY
CT
3072.44
4.06
1
2
4
-2
0.74
-0.163
22.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5875
1.91
14
Residue Composition
number
0
A
0
R
2
N
1
D
6
C
1
E
0
Q
5
G
1
H
0
I
1
L
0
K
0
M
1
F
4
P
0
S
6
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 2 D: 1 C: 6 E: 1 Q: 0 G: 5 H: 1 I: 0 L: 1 K: 0 M: 0 F: 1 P: 4 S: 0 T: 6 W: 1 Y: 0 V: 1
Chemical Descriptors
30 reviewed residue count
C126H187N35O43S6 sequence-only estimate (linear, free termini)
3072.44 sequence-only estimate (linear, free termini)
4.06 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
0.74 sequence-only estimate (linear, free termini)
-0.163 sequence-only estimate (linear, free termini)
Evidence Records 9 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

DRAMP

Other

It inhibited HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells (EC50 308 nM) and cytotoxicity (TC50 6.2 uM), therapeutic index (~20) (Ireland et al., 2008) .
Evidence 2 Activity

Activity

Antifungal

Source & Reference

DRAMP CAFPdb Antifungipept

Other

It inhibited HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells (EC50 308 nM) and cytotoxicity (TC50 6.2 uM), therapeutic index (~20) (Ireland et al., 2008) .
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
dbAMP 3.0 classified under the Anti-parasitic function class.
It inhibited HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells (EC50 308 nM) and cytotoxicity (TC50 6.2 uM), therapeutic index (~20) (Ireland et al., 2008) .
Evidence 4 Activity

Activity

Antiviral

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
dbAMP 3.0 classified under the Anti-viral function class.
It inhibited HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells (EC50 308 nM) and cytotoxicity (TC50 6.2 uM), therapeutic index (~20) (Ireland et al., 2008) .
Evidence 5 Activity

Activity

% Hemolysis
Hemolysis
75 %
[Ref:16872274] It has 75% hemolytic activity at 25.0 µM against human type A red blood cells.

Target

human type A red blood cells

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Biochem J. 2006 Nov 15 400(1):1-12.##Biopolymers. 2008 90(1):51-60.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 6 Activity

Activity

75% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
75% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability. | Biochem J | 2006
Evidence 7 Activity

Activity

IC50
Toxicity
6.17 µM
Cytotoxic
IC50 | 6.17 | µM | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Cyclotides as natural anti-HIV agents | Biopolymers | 2008
Evidence 8 Activity

Activity

IC50
Toxicity
6170 nM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref:16872274] It has 75% hemolytic activity at 25.0 µM against human type A red blood cells. | Cytotoxicity: [Ref.18008336]CEM-SS cells:IC50=6170 nM.

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem J. 2006 Nov 15 400(1):1-12.##Biopolymers. 2008 90(1):51-60.
Evidence 9 Hemolysis

Activity

75 %
% Hemolysis
[Ref:16872274] It has 75% hemolytic activity at 25.0 µM against human type A red blood cells.
Hemolysis

Target

human type A red blood cells

Source & Reference

APD_complete PD_Hemolysis
Biochem J. 2006 Nov 15 400(1):1-12.##Biopolymers. 2008 90(1):51-60.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.